Home > Insider Trading > Filing (0000914190-12-000256)

Filing Details

Accession Number:: 0000914190-12-000256
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-02 13:00:00
Reporting Period:: 2012-03-30

Filing Date:: 2012-04-02
Accepted Time:: 2012-04-02 16:20:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133869	Nile Therapeutics Inc.	NLTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1411726	Daron Evans	C/O Nile Therapeutics, Inc. 4 West 4Th Avenue, Suite 400 San Mateo CA 94402	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-30	12,500	$0.00	25,652	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (Right to Buy)	Acquisiton	2012-03-30	9,375	$0.00	9,375	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,375			No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,200	Indirect	By Spouse
Common Stock	200	Indirect	By Daughter
Common Stock	200	Indirect	By Son

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$2.71	2017-09-17	169,797	169,797	Direct
Common Stock	Stock Option (Right to Buy)	$2.71	2017-09-17	239,899	239,899	Direct
Common Stock	Stock Option (Right to Buy)	$0.88	2019-01-15	49,020	49,020	Direct
Common Stock	Stock Option (Right to Buy)	$0.89	2019-06-24	85,628	85,628	Direct
Common Stock	Stock Option (Right to Buy)	$0.30	2020-07-08	200,000	200,000	Direct
Common Stock	Stock Option (Right to Buy)	$0.37	2020-07-26	250,000	250,000	Direct
Common Stock	Stock Option (Right to Buy)	$0.69	2021-04-18	50,000	50,000	Direct
Common Stock	Warrant (Right to Buy)	$1.25	2014-07-07	988	988	Direct
Common Stock	Warrant (Right to Buy)	$1.71	2014-07-07	988	988	Direct
Common Stock	Warrant (Right to Buy)	$2.28	2014-07-07	1,976	1,976	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-09-17	169,797	169,797	Direct
2017-09-17	239,899	239,899	Direct
2019-01-15	49,020	49,020	Direct
2019-06-24	85,628	85,628	Direct
2020-07-08	200,000	200,000	Direct
2020-07-26	250,000	250,000	Direct
2021-04-18	50,000	50,000	Direct
2014-07-07	988	988	Direct
2014-07-07	988	988	Direct
2014-07-07	1,976	1,976	Direct

Footnotes

The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.
On 9/17/2007, the Reporting Person was granted an option to purchase up to 288,458 shares of common stock of the Issuer. Up to 1/3 of the shares subject to the option may vest annually (or a pro rata portion thereof for a period of less than a full year) based on the achievement of certain performance milestones as determined by the Compensation Committee of the Board of Directors (the 'Committee') of the Issuer. On 3/4/2008, the Committee determined that options for the prorated period ending 12/31/2007 would vest in the amount of 76,528 shares, with options to purchase 8,034 shares being forfeited. On January 16, 2009, the Committee determined that options for the period ending 12/31/2008 would vest in the amount of 43,269 shares, with options to purchase 52,884 shares being forfeited. On 1/19/2010, the Committee determined that options for the period ending 12/31/2009 would vest in the amount of 50,000 shares, with options to purchase 46,153 shares being forfeited.
Currently exercisable.
On June 24, 2009, the Reporting Person was granted an option to purchase up to 100,000 shares of common stock of the Issuer, 25,000 of which were immediately exercisable. Vesting of 50,000 of the shares subject to the option was based on the achievement of certain performance milestones (or a pro rata portion thereof for a five-month period of such milestones) following the date of grant. On February 15, 2010, the Reporting Person's right to purchase 42,500 shares of such 50,000-share installment vested based on the achievement of such milestones; the remaining 7,500 shares of such installment were forfeited. Vesting of the final 25,000 shares of the total grant was subject to certain other performance milestones (or a pro rata portion thereof). On January 3, 2011, the Reporting Person's right to purchase 18,128 shares of such final 25,000-share installment vested based on the achievement of such milestones; the remaining 6,872 shares of such installment were forfeited.
This option vests in twelve equal quarterly installments over three years with the first installment vesting on September 30, 2010.
The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.